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The bone microenvironment is composed of niches that house cells across variable oxygen tensions. However, the
contribution of oxygen gradients in regulating bone and blood homeostasis remains unknown. Here, we generated
mice with either single or combined genetic inactivation of the critical oxygen-sensing prolyl hydroxylase (PHD)
enzymes (PHD1–3) in osteoprogenitors. Hypoxia-inducible factor (HIF) activation associated with Phd2 and Phd3
inactivation drove bone accumulation by modulating osteoblastic/osteoclastic cross-talk through the direct regu-
lation of osteoprotegerin (OPG). In contrast, combined inactivation of Phd1, Phd2, and Phd3 resulted in extremeHIF
signaling, leading to polycythemia and excessive bone accumulation by overstimulating angiogenic–osteogenic
coupling.We also demonstrate that genetic ablation of Phd2 and Phd3was sufficient to protect ovariectomizedmice
against bone loss without disrupting hematopoietic homeostasis. Importantly, we identify OPG as a HIF target gene
capable of directing osteoblast-mediated osteoclastogenesis to regulate bone homeostasis. Here, we show that co-
ordinated activation of specific PHD isoforms fine-tunes the osteoblastic response to hypoxia, thereby directing two
important aspects of bone physiology: cross-talk between osteoblasts and osteoclasts and angiogenic–osteogenic
coupling.
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Bone development and homeostasis are achieved through
an intricate balance between osteoblastic bone formation
and osteoclastic bone resorption (Zaidi 2007; Khosla et al.
2008). Mammalian bone develops through endochondral
ossification, a process that requires the coordination of os-
teoblasts and blood vessel invasion into the cartilaginous
template to trigger the formation of the primary ossifica-
tion center, highlighting the importance of angiogenesis
during bone formation (Kronenberg 2003; Provot and Schi-
pani 2005; Maes 2013). Maintenance of bone homeostasis
is achieved by coupling bone formation with osteoblastic
bone resorption. In particular, the RANK/RANKL/osteo-
protegerin (OPG) axis contributes to this process by fa-
cilitating osteoblast-mediated osteoclastogenesis (Boyle
et al. 2003). Deregulation of bone homeostasis is a hall-
mark of pathophysiological bone disease and occurs
due to imbalances in osteogenic–angiogenic coupling or
between bone-forming osteoblasts and bone resorption
by osteoclasts. Increased bone results in osteopetrosis,
whereas osteoporosis is associated with bone loss (Tei-
telbaum and Ross 2003; Seeman and Delmas 2006). Elu-
cidating the molecular mechanisms that control bone
homeostasis within the bone microenvironment is need-
ed in order to identify novel therapeutic strategies to
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generate functional bone to treat chronic metabolic bone
disorders where the options for treatment are still limited.
The bone microenvironment is a particularly hypoxic
microenvironment. Most adult tissues are well vascular-
ized, allowing for the promotion of oxygen transport
with normal median interstitial oxygen tension (pO2) val-
ues ranging from 3% to 9% (Vaupel et al. 1989). In con-
trast, pO2 levels in the bone range from <1% in hypoxic
regions up to 6% in sinusoidal cavities (Mohyeldin et al.
2010). Low oxygen tensions in the bone are likely a result
of low oxygen levels in sinusoidal blood and high levels of
oxygen consumption by hematopoietic cells. Blood flow
in the bone travels from the central artery into arterioles,
capillaries, and finally sinusoids, accompanied by a pro-
gressive drop in blood velocity and oxygenation. It has
been estimated that the blood flow rate in sinusoids is
approximately 1/10 to 1/20 of that found in arterioles. In
addition to low blood flow and oxygen tension within si-
nusoids,mathematicalmodels predict that a layer of three
myeloid progenitors is sufficient to consumemost oxygen
provided by a nearby sinusoid (Chow et al. 2001; Winkler
et al. 2010, Rankin et al. 2011). Immunohistochemical
staining and microcomputer tomography (μCT) imaging
of bone demonstrate that blood vessels within the adult
bone and bone marrow display large structural and spatial
distributional heterogeneity (Kusumbe et al. 2014; Regan
et al. 2014; Spencer et al. 2014). Hence, this tissue displays
vascular heterogeneity resulting in regionally defined ar-
eas of low oxygen tension or hypoxia. Despite the fact
that the bone resides in a hypoxic microenvironment,
the contribution of this oxygen gradient and the role of
the cellular oxygen sensors in regulating bone homeosta-
sis remain poorly understood.
Prolyl hydroxylase (PHD) enzymes (PHD1, PHD2, and
PHD3) are the primary cellular oxygen sensors (Semenza
2001). Most notably, PHD enzymes use oxygen as a mo-
lecular substrate to regulate the protein stability of the
hypoxia-inducible transcription factors (HIF-1α and HIF-
2α) in an oxygen-dependent manner (Schofield and Rat-
cliffe 2004). At oxygen tensions >5%, the PHD enzymes
regulate HIF protein stability by catalyzing the hydroxyl-
ation of HIF transcription factors on conserved proline res-
idues, targeting them for proteosomal degradation by the
von Hippel-Lindau (pVHL) ubiquitin ligase complex.
When oxygen tensions fall below 5%, PHD enzyme activ-
ity is diminished, and HIF-1α and HIF-2α are stabilized
and activate the expression of genes involved in diverse
physiological conditions ranging from erythropoiesis to
metabolism to angiogenesis (Semenza 2012). Thus, PHD
enzymes provide a direct link between oxygen availability
and the regulation of HIF transcriptional activity. While
the PHD isoforms have nearly ubiquitous tissue expres-
sion, the tissue-specific role of each isoform in regulating
HIF protein levels remains poorly defined.
Here, we sought to dissect the physiologic role of oxy-
gen-sensing PHD1, PHD2, and PHD3 enzymes in the reg-
ulation of bone homeostasis. For this purpose, we used a
genetic approach to specifically inactivate Phd1, Phd2,
and Phd3 in cells of the osteoblastic lineage using Cre-
loxP-mediated recombination. In addition to coordinating
osteoblastic–angiogenic coupling, we identified a previ-
ously unknown role for the PHD/HIF signaling path-
way in the osteoblastic regulation of osteoclastogenesis
through the direct regulation of OPG. Importantly, inacti-
vation of selective PHD isoforms within the cells of the
osteoblastic lineage inhibited bone loss in ovariectomized
mice. Thus, molecular oxygen, through the PHD/HIF sig-
naling pathway, plays a central role in bone homeostasis
by controlling both angiogenesis and osteoclastogenesis,
and therapeutic targeting of PHDenzymes can potentially
be used for the treatment of bone disorders.
Results
Generation of mice with osteoblastic inactivation of
PHDs leads to differential activation of HIF signaling
Osteoblasts and osteocytes reside in the bone marrow,
where there exists both heterogeneous areas of vasculari-
zation and oxygen tension (Regan et al. 2014; Spencer
et al. 2014). In support of these findings, we used pimoni-
dazole (PIMO) staining to detect microregional levels of
functional hypoxia and found thatwithinwhole-bone sec-
tions of 8-wk-old mice, strong signals were detected with-
in both endosteal osteoblasts and osteocytes (Fig. 1A).
Comparedwith staining of the kidney,where nearly all tu-
bular cells in the renal medullary cells stain positively for
PIMO (Fig. 1B), quantification of PIMO-stained cells in the
bone revealed 72% of osteocytes and 79% of endosteal os-
teoblasts stained for PIMO, demonstrating heterogeneous
oxygen tension within the osteoblastic niche (Fig. 1C).
Given these findings, we next sought to determinewheth-
er the PHD isoenzymes, which act as the oxygen sensors
of theHIF signaling pathway,were expressed in bone cells.
Primary osteoblasts were isolated from mice at postnatal
days 0 and 7 and from 4-wk-oldmice. Real-time PCR anal-
ysis confirmed the presence of bone-specific proteins, and
Western blot analysis of whole-cell lysates revealed the
presence of all three PHDs isoforms at all age points
(Fig. 1D,E). Given these findings, we sought to identify
the role of the PHD enzymes in regulating in vivo osteo-
blastic HIF signaling, osteoblast function, and bone
homeostasis.
For this purpose, we systematically interrogated the in-
dividual and collective function of the three PHD isoen-
zymes by generating homozygous mice for the following
conditional alleles: Phd1fl/fl, Phd2fl/fl, and Phd3fl/fl (sin-
gle); Phd1fl/fl; Phd2fl/fl, Phd2fl/fl; Phd3fl/fl, and Phd1fl/fl;
Phd3fl/fl (double); and Phd1fl/fl; Phd2fl/fl; Phd3fl/fl (triple).
These mice were then crossed to mice expressing Cre-
recombinase under the control of the osterix (OSX) pro-
moter to generate OSX-Cre; Phd1fl/fl, OSX-Cre; Phd2fl/fl,
OSX-Cre; Phd3fl/fl, OSX-Cre; Phd1fl/fl; Phd2fl/fl, OSX-
Cre; Phd2fl/fl; Phd3fl/fl, OSX-Cre; Phd1fl/fl; Phd3fl/fl, and
OSX-Cre; Phd1fl/fl; Phd2fl/fl; Phd3fl/fl mutant mice. OSX-
Cre is a well-characterized transgene that mediates effi-
cient Cre-recombinase activity in cells of the osteoblast
lineage (Rodda and McMahon 2006). PHD activity is lost
in osteoprogenitors upon Cre-mediated LOX-P excision
of essential of Fe2+-binding residues within exon 2 of
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each PHD isoform (Takeda et al. 2006, 2008). Genomic
PCR analysis confirmed efficient and specific targeted
deletion, as noted by the presence of the recombined
(lox-P) allele in bone tissue from mutants expressing
Cre-recombinase (Supplemental Fig. S1A,B).
PHD enzymes regulate HIF protein stability through
proline hydroxylation, which mediates pVHL binding
and subsequent ubiquitin-mediated protein degradation.
Loss of PHD activity results in increased HIF stability
and the subsequent transactivation of HIF target genes
(Semenza 2001). Real-time PCR analysis of whole-bone
homogenates revealed that genetic inactivation of some
but not all combinations of PHD isoenzymes in OSX-
expressing cells resulted in the up-regulation of the HIF
target genes erythropoietin (Epo), vascular endothelial
growth factor (Vegf), and phosphoglycerate kinase (Pgk)
(Fig. 1F). Osteoblastic loss of all three PHD isoforms re-
sulted in the highest increase in the mRNA expression
of HIF target genes, whereas combined loss of PHD2 and
PHD3 and combined loss of PHD1 and PHD2 resulted in
amodest increase of Epo,Vegf, and Pgk expression. In con-
trast, loss of PHD1 and PHD3 had no effect on HIF target
gene expression. Consistent with these findings, immu-
nohistological analysis revealed increased intensity of nu-
clear HIF-1α and HIF-2α staining in the osteoblasts and
osteocytes of OSX-Cre; PHD1fl/fl; PHD2fl/fl; PHD3fl/fl,
OSX-Cre; PHD2fl/fl; PHD3fl/fl, and OSX-Cre; PHD1fl/fl;
PHD2fl/fl mutant mice but not OSX-Cre; PHD1fl/fl;
PHD3fl/flmutant mice (Fig. 1G,H). Thus, differential acti-
vation of HIF signaling can be achieved in bone tissue
Figure 1. Differential regulation of osteoblastic HIF signaling through selective inactivation of PHDs. (A) Representative PIMO staining
of tibial sections of mice at 8 wk of age. Arrowheads point to osteoblasts at the endosteal bone surface and osteocytes. Positively stained
cells are marked with black arrowheads, and negative cells are marked with open arrowheads. (B) PIMO staining of a mouse kidney. (C )
Quantification of PIMO-stained osteocytes and endosteal osteoblasts form tibia isolated from awild-typemouse. (D) Real-time PCR anal-
ysis of runx2 (RUNX), osterix (OSX), collagen1α (Col1a), and osteocalcin (OCN) mRNA expression in calvarial osteoblasts isolated from
mice at postnatal days 0 and 7 and at 4 wk of age. (E) Western blot analysis of whole-cell lysates isolated from calvarial osteoblasts at post-
natal days 0 and 7 and at 4 wk of age. (F ) Real-time PCR analysis of EPO, VEGF, and PGKmRNA expression in bone tissues isolated from
littermate control mice (C) and OSX-Cre mutant mice. For each group analyzed, n = 4. (UD) Undetectable levels. (G,H) Immunohisto-
chemical analysis of HIF-1α (G, top) and HIF-2α (G, bottom) expression in osteoblasts lining the endosteal surface and in osteocytes
(H) in OSX-Cre mutant tibias. Arrowheads point to osteoblasts and osteocytes expressing HIF-1α or HIF-2α.
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through the selective inactivation of specific PHD isoform
combinations.
Selective inactivation of PHD modulates HIF signaling
dosage to differentially regulate bone and hematopoietic
homeostasis
Intriguingly, histological and μCTanalysis of theOSX-Cre
PHD mutant mice revealed increases in trabecular bone
volume that were positively correlated with active HIF
signaling, with the most severe phenotypes occurring
in mice with the highest levels of HIF transcriptional ac-
tivity. Specifically, examination of 12-wk-old OSX-Cre;
Phd1fl/fl; Phd2fl/fl; Phd3fl/flfemurs revealed an excessive
increase in trabeculae in the metaphyseal and diaphyseal
regions of the long bones when compared with their sex-
and age-matched littermate controls (Fig. 2A,B; Sup-
plemental Table S1). These microarchitectural changes
were associated with diminished bone marrow cellularity
and trabecularization of the cortical bone, as marked by
the replacement of cortical bone by trabecular-like porous
bone structures (Fig. 2B). In support of these findings, μCT
analysis of the mid-shaft of the femur revealed that aver-
age cortical thickness was substantially lower in OSX-
Cre; Phd1fl/fl; Phd2fl/fl; Phd3fl/fl mutants when compared
with age- and sex-matched littermate controls (Fig. 2D;
Supplemental Table S3). In contrast, combined osteoblas-
tic inactivation of Phd1 with Phd2 and Phd2 with Phd3
led to a significant increase in trabecular bone volume
as a consequence of increased trabecular numbers. Impor-
tantly, these changes were not associated with excessive
ossification of the long bones (Fig. 2A–C; Supplemental
Table S1). In addition, μCT analysis revealed that loss of
any combination of dual PHD isoforms did not signifi-
cantly alter the average cortical bone thickness between
OSX-PHD mutants and their sex- and age-matched
Figure 2. Selective inactivation of specific PHD isoform combinations increases trabecular bone volume without disrupting blood ho-
meostasis. (A) Representative μCT images of distal femurs isolated from 12-wk-old control (CNTRL) and OSX-Cre mutant mice (axial
view of metaphyseal region). (B) Representative images of H&E-stained proximal tibias isolated from 12-wk-old control (CNTRL) and
OSX-Cre mutant mice. (C ) μCT analysis of trabecular bone volume (BV/TV) and trabecular number (Tb.N) from 12-wk-old control (C)
and OSX-Cre mutant mice. For each group analyzed, OSX-Cre; Phd1fl/fl; Phd2fl/fl; Phd3fl/fl (PH1/2/3), n = 6; OSX-Cre; Phd2fl/fl; Phd3fl/fl
(PH2/3), n = 8; OSX-Cre; Phd1fl/fl; Phd2fl/fl (PH1/2), n = 7; and OSX-Cre; Phd1fl/fl; Phd3fl/fl (PH1/3), n = 7. (D) μCT analysis of cortical
bone thickness (Ct.Th) of 12-wk-old control (C) and OSX-Cre mutant mice. For each group analyzed, OSX-Cre; Phd1fl/fl; Phd2fl/fl;
Phd3fl/fl(PH1/2/3), n = 6; OSX-Cre; Phd2fl/fl; Phd3fl/fl(PH2/3), n = 8; OSX-Cre; Phd1fl/fl; Phd2fl/fl (PH1/2), n = 7; and OSX-Cre; Phd1fl/fl;
Phd3fl/fl (PH1/3), n = 4. (E) Percentage of hematocrit (HCT) in control (C) and OSX-Cre mutant mice at 12 wk of age. For each group an-
alyzed, OSX-Cre; Phd1fl/fl; Phd2fl/fl; Phd3fl/fl(PH1/2/3), n = 4; OSX-Cre; Phd2fl/fl; Phd3fl/fl(PH2/3), n = 5; OSX-Cre; Phd1fl/fl; Phd2fl/fl (PH1/
2), n = 5; andOSX-Cre; Phd1fl/fl; Phd3fl/fl (PH1/3), n = 5. All data are represented asmean ± standard error of themean (SEM). (∗) P < 0.05; (∗∗)
P < 0.01; (∗∗∗) P < 0.001, determined by Student’s t-test.
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littermate controls (Fig. 2D; Supplemental Table S3). Im-
portantly, histological and μCT analysis revealed no dif-
ferences in bone volume, trabecular number, trabecular
thickness, or trabecular separation between OSX-Cre;
Phd1fl/fl; Phd3fl/fl, OSX-Cre; Phd1fl/fl, OSX-Cre; Phd2fl/fl,
or OSX-Cre; Phd3fl/fl and their sex- and age-matched lit-
termate controls (Fig. 2A–C; Supplemental Fig. S2; Sup-
plemental Table S2). These findings demonstrate that
selective inactivation of specific PHD isoform combina-
tions differentially regulates trabecular but not cortical
bone homeostasis by modulating HIF signaling dosage.
The osteoblastic niche plays an important role in regu-
lating multiple hematopoietic lineages (Wu et al. 2009).
We previously demonstrated that genetic loss of either
pVHL or all three PHD isoforms in cells of the osteoblast
lineage augmentsHIF signaling andmodulates erythropoi-
esis by directly regulating the production of EPO within
the local bone marrow microenvironment. Osteoblastic
EPO production led to the expansion of the erythroid
lineage, resulting in the development of polycythemia as
marked by a significant increase in hematocrit and red
blood cell (RBC) numbers (Rankin et al. 2012). Given these
observations, we sought to determine whether selective
inactivation of dual PHD isoform combinations would
also alter mature hematopoietic linages. To address this
question, we compared cells of the myeloid and lymphoid
lineages from peripheral blood isolated from 12-wk-old
OSX-Cre; Phd1fl/fl; Phd2fl/fl; Phd3fl/fl, OSX-Cre; Phd1fl/fl;
Phd2fl/fl, OSX-Cre; Phd2fl/fl; Phd3fl/fl, and OSX-Cre;
Phd1fl/fl; Phd3fl/flmutant mice. In support of our previous
work, genetic inactivation of all PHD isoforms signifi-
cantly elevated RBCs and hematocrit while diminishing
lymphocyte numbers (Fig. 2E; Supplemental Table S4).
In contrast, despite elevation of the HIF target gene Epo
and the expansion of the osteoblastic compartment of
the hematopoietic niche, selective inactivation of dual
PHD isoform combinations did not alter hematopoietic
homeostasis in OSX-PHD mutant mice when compared
with controls. Both mature myeloid and lymphoid blood
lineages in OSX-Cre; Phd1fl/fl; Phd2fl/fl, OSX-Cre; Phd2fl/
fl; Phd3fl/fl, and OSX-Cre; Phd1fl/fl; Phd3fl/fl mice were in-
distinguishable from age- and sex-matched littermate
control mice (Supplemental Table S4). Importantly, this
demonstrates that changes in bone homeostasis can be
achieved through both collective and selective inhibition
of the PHD isoforms; however, functional changes in he-
matopoiesis require the loss of all three PHD isoforms
within the local bone marrow microenvironment.
Osteogenic–angiogenic coupling is not required
for HIF-mediated changes in bone homeostasis
The relationship between angiogenesis and osteogenesis
is highlighted by lineage tracing studies demonstrating
that, during endochondral ossification, osteoblast precur-
sors reside in close spatial and temporal association with
capillary bed invasion (Maes et al. 2010a). This coupling
of osteogenesis to angiogenesis is mediated in part by
HIF signaling (Wang et al. 2007; Schipani et al. 2009). In
support of this, we found that genetic inactivation of all
three PHD isoforms led to severe HIF activation marked
in part by the up-regulation of VEGF mRNA (Fig.
1F). Thiswas associatedwith a stark increase in trabecular
bone and hypervascularization, as demonstrated by CD31
immunohistochemistry (Fig. 3A). Surprisingly, despite
the increased trabecular bone volume seen in OSX-Cre;
Phd2fl/fl; Phd3fl/fl and OSX-Cre; Phd1fl/fl; Phd2fl/fl mice,
CD31 staining showed no differences in microvascular
density betweenOSX-Cre; Phd2fl/fl; Phd3fl/fl and Phd1fl/fl;
Phd2fl/fl mutant mice when compared with their litter-
mate controls (Fig. 3A). In support of this, quantification
of vasculature within the metaphyseal and diaphyseal re-
gions of whole-bone sections isolated from 12-wk-old
mice revealed indistinguishable numbers of blood vessels
between OSX-Cre; Phd2fl/fl; Phd3fl/fl, OSX-Cre; Phd1fl/fl;
Phd2fl/fl, and littermate controls (Fig. 3B). Recent reports
demonstrate that CD31high/endomucinhigh blood vessels
are associated with coupling osteogenesis to angiogenesis
(Kusumbe et al. 2014). Serial sections of tibias isolated
from 8-wk-old OSX-Cre; Phd2fl/fl; Phd3fl/fl mutants and
littermate control mice were stained for either CD31 or
endomucin (Fig. 3C). Quantification of metaphyseal
and diaphyseal regions of blood vessels staining for
both markers revealed no differences in the number of
CD31highendomucinhigh blood vessels between mutants
and littermate controls (Fig. 3C). In addition, only a mod-
est increase in VEGF mRNA expression was detected
between OSX-Cre; Phd2fl/fl; Phd3fl/fl and their controls,
and no differences were detected between the OSX-Cre;
Phd1fl/fl; Phd2fl/fl mutant and control mice (Fig. 1F). Fur-
thermore, ELISAs revealed that circulating levels of
VEGF in serum remained unaffected by genetic inacti-
vation of PHD isoenzymes (Fig. 3B). These data suggest
that PHD/HIF signaling can regulate bone homeostasis in-
dependently of HIF-mediated neoangiogenesis.
Genetic inactivation of osteoblastic Phd2 and Phd3
inhibits osteoblast-mediated osteoclastogenesis
through the modulation of OPG
Our findings detailed above led us to the unexpected con-
clusion that the PHD oxygen sensors could modulate
bone homeostasis independent ofHIF-mediated angiogen-
esis. We therefore considered the possibility that PHD/
HIF signaling could regulate bone homeostasis by a cell-
autonomous mechanism. Given that combined genetic
inactivation of Phd2 and Phd3 resulted in the most strik-
ing increase in trabecular bone volume that was not as-
sociated with increased VEGF production or enhanced
bone microvasculature density, we analyzed the osteo-
clast compartment in OSX-Cre; Phd2fl/fl; Phd3fl/flmutant
mice to determine the contribution that these PHD en-
zymes had on bone resorption. Alcian blue histological
staining of proximal tibias revealed increased carti-
lage remnants in the trabeculae of 12-wk-old OSX-Cre;
Phd2fl/fl; Phd3fl/fl mice when compared with littermate
controls, indicating impaired remodeling of the primary
spongiosa (Fig. 3D). Quantitative histomorphometry
of tartrate-resistant acid phosphatase (TRAP)-positive
cells showed a marked reduction in TRAP-positive
Osteoblastic HIF signaling regulates OPG
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multinucleated trabecular and endosteal osteoclasts in
OSX-Cre; Phd2fl/fl; Phd3fl/fl mutant mice (Fig. 3E,F).
The RANK/RANKL/OPG axis contributes to bone ho-
meostasis by facilitating osteoblast-mediated osteoclasto-
genesis, amajor element of proper bone remodeling (Boyle
et al. 2003). Given the reduction in osteoclast numbers,
we next examined the OPG/RANK/RANKL signaling
pathway in our mutant mice. In support of our static his-
tomorphometic data, molecular analysis of whole-bone
homogenates isolated from OSX-Cre; Phd2fl/fl; Phd3fl/fl
mice revealed increased expression of OPG but not
RANKL mRNA levels when compared with control
Figure 3. Osteoblastic inactivation of PHD2 and PHD3 inhibits osteoclastogenesis. (A) Representative images of CD31 immunohisto-
chemistry to visualize vascularization in control (CNTRL) and OSX-Cre PHDmutantmice. Blood vessels are indicated with black arrow-
heads. (B, top) Quantification of blood vessels in bones in 12-wk-old control and OSX-Cre PHDmutant mice. (Bottom) Analysis of VEGF
protein levels in the serum of 12-wk-old control (C) and OSX-Cre PHD mutant mice. (C, left) Representative images of serial sections
stained for CD31 and endomucin. Colocalized staining of blood vessels is indicated with black arrowheads. (Right) Quantification of
CD31high/endomucinhigh blood vessels in 8-wk-old control and mutant mice. (D) Representative images of Alcian blue-stained control
(CNTRL) and OSX-Cre; Phd2fl/fl; Phd3fl/fl (PH2/3) mutant proximal tibias isolated from 12-wk-old mice. The arrowheads point to unre-
modeled cartilage. (E) Representative images of tartrate-resistant acid phosphatase (TRAP)-stained proximal tibias isolated from 12-wk-
old control and mutant mice. The arrowheads point to TRAP-positive osteoclasts. (F ) Quantification of TRAP-positive multinucleated
osteoclasts in proximal tibias. The number of trabecular and endosteal osteoclasts per bone surface (trabecular N.Oc./BS, n = 6; endosteal
N.Oc/BS, n = 4) is shown. (G) Real-time PCR analysis of OPG and RANKLmRNA in bone tissues isolated from 12-wk-old mice. For each
group analyzed, n = 4. (H) Real-time PCR analysis of OPG and RANKL mRNA isolated from primary calvarial cultures. For each group
analyzed, n = 4. (I ) Analysis of OPG and RANKL protein levels in the serum of 12-wk-old mice as determined by ELISA. For each group
analyzed, n = 4. (J, left) Representative image of dual calcein-labeled femurs from 12-wk-old mice. (Right) Assessment of the mineral ap-
position rate (MAR) and bone formation rate per bone surface (BFR/BS) by quantification of dual calcein-labeled sections of distal femur
from 12-wk-old mice. For each group analyzed, n = 6. (K ) Quantification of trabecular osteoblast numbers per bone surface (n = 3).
(L) Quantification of TRAP-positive colonies from cocultures of wild-type bonemarrow stromal cells and primary osteoblast cultures iso-
lated from PHD2fl/fl; PHD 3fl/fl treated with either control or adeno-CRE virus (n = 3). (M ) Analysis of secreted OPG and RANKL protein
levels from coculture experiments as determined by ELISA (n = 3). All data are represented as mean ± standard error of the mean (SEM). (∗)
P < 0.05; (∗∗) P < 0.01; (∗∗∗) P < 0.001, determined by Student’s t-test.
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mice (Fig. 3G). Because total bone preparations contain
many cell types, we also directly assessed whether mu-
tant osteoblasts from OSX-Cre; Phd2fl/fl; Phd3fl/fl pro-
duced more OPG than control osteoblasts. Notably,
cultured primary calvarial cultures isolated from OSX-
Cre; Phd2fl/fl; Phd3fl/fl mice showed increased expression
of OPG but not RANKL mRNAs levels (Fig. 3H). Accord-
ingly, these mutant mice also had increased OPG but not
RANKL serum levels when compared with littermate
controls (Fig. 3I). We next cocultured primary osteoblasts
isolated from the calvaria of Phd2fl/flfl; Phd3fl/flmice with
wild-type bone marrow stromal cells. We found that in
vitro, genetic inactivation of PHD2 and PHD3 resulted
in diminished formation of TRAP-stained cells when
compared with controls (Fig. 3L). In addition, we found in-
creased secretion of OPG but not RANKL from the media
collected from cocultures of osteoblasts harboring geneti-
cally inactivated PHD2 and PHD3 when compared with
controls (Fig. 3M).
Dynamic histomorphometry revealed no differences in
mineral apposition rates (MARs), bone formation rates, or
osteoblast numbers between OSX-Cre; Phd2fl/fl; Phd3fl/fl
mice and littermate controls, suggesting that bone forma-
tion rates were similar between the two groups of mice
(Fig. 3J,K). In support of our in vivo findings, in vitro pri-
mary calvarial cells isolated from OSX-Cre; Phd2fl/fl;
Phd3fl/fl mice cultured under osteogenic conditions for
14 d showed no differences in alkaline phosphatase
(ALP) activity or the expression of osteoblastic marker
genes Col1α and BSP, indicating that osteoblastic loss of
both PHD2 and PHD3 did not promote changes in osteo-
blast differentiation (Supplemental Fig. S3A,B). Taken to-
gether, we demonstrate that PHD2 and PHD3 influence
bone homeostasis through themodulation of OPG to sup-
press osteoblast-mediated osteoclastogenesis.
HIF signaling is both necessary and sufficient
to inhibit osteoclastogenesis and bone resorption
through the modulation of OPG
We next sought to elucidate the molecular mechanism
modulating the expression of OPG within our PHD mu-
tant mice. To determine whether osteoblasts express
OPG in aHIF-dependentmanner, we cultured the primary
osteoblast cell line MC3T3 E1 in either 21% oxygen (nor-
moxia) or 0.5% oxygen (hypoxia) to induce HIF signaling
in vitro. In response to hypoxia, we saw an increase in
mRNA expression of the HIF target gene Vegf as well as
a twofold induction of OPG mRNA levels, indicating
that HIF signaling drives OPG expression under physio-
logic conditions (Fig. 4A).
To access the contribution of HIF-1α and HIF-2α in the
modulation of OPG, MC3T3 E1 cells were transiently
transfected with HIF variants in which both prolyl hy-
droxylation sites were replaced by alanine. These variants
cannot be hydroxylated by PHDs and are therefore consti-
tutively stabilized regardless of oxygen tension (Kondo
et al. 2002). Expression of both nondegradable HIF-1α
and HIF-2α variants resulted in augmented HIF activity,
as demonstrated by the induction of the HIF target gene
Vegf (Supplemental Fig. S4A). However, statistically sig-
nificant increases in OPG mRNA expression were seen
only in cells expressing constitutively active HIF-2α (Fig.
4B). Notably, as only a moderate induction of VEGF
mRNA was seen in cells expressing constitutively active
HIF-1α, we could not dismiss the possibility that HIF-1α
also has the potential to direct the regulation of OPG (Sup-
plemental Fig. S4A).
HIF transcriptional activity can modulate gene expres-
sion through direct and indirect mechanisms. To deter-
mine whether OPG is a direct target of HIF-2α, we
searched theTnfrsf11B (OPG)promoter for consensushyp-
oxia-responsive element (HREs) containing a conserved
RCGTG sequence. Promoter analysis revealed the pres-
ence of HREs within the Tnfrsf11B (OPG) promoter adja-
cent to the transcriptional start site. To evaluate HIF-2α
binding to HREs present in this region, we transfected
MC3T3 E1 cells with a HA-tagged constitutively active
variant of HIF-2α (HA-HIF-2αdPA). Western blot analysis
of cell lysates confirmed the presenceof thenondegradable
HA-tagged HIF-2α variant (Supplemental Fig. S4B). Chro-
matin immunoprecipitation (ChIP) analysis revealed
that HIF-2α directly bound to HREs in the Tnfrsf11B pro-
moter, with binding exceeding that of HIF-2α within
the Vegf HRE promoter, an established HIF target gene
(Fig. 4C). These data indicate that OPG is a direct HIF-2α
target gene.
Next, to directly interrogate the contribution of os-
teoblastic HIF signaling in mediating osteoclastogenesis
and bone homeostasis, we bredOSX-Cremice to transgen-
ic mice in which conditional alleles of either theHif-1α or
Hif-2α (OSX-Cre; Hif1dPA and OSX-Cre; Hif2dPA) vari-
ants escape recognition of pVHL, resulting in the constitu-
tive activation of HIF signaling (Kim et al. 2006). Real-
time PCR analysis of whole-bone homogenates revealed
augmented HIF activity in both OSX-Cre; Hif1dPA and
OSX-Cre; Hif2dPA mice. Isoform specificity was con-
firmed by examination of genes regulated by both HIF-
1α and HIF-2α (Vegf) or uniquely by HIF-1α (Pgk) or HIF-
2α (Epo) (Supplemental Fig. S4C). Similar to the OSX-
Cre; Phd2fl/fl; Phd3fl/flmice, OSX-Cre; Hif2dAP exhibited
statistically significant increases in mRNA expression of
OPG, an increased ratio of serumOPG to RANKL, dimin-
ished numbers of trabecular and endosteal osteoclasts,
and no differences in osteoblast numbers, thereby pheno-
copying our OSX-Cre; Phd2fl/fl; Phd3fl/flmutantmice (Fig.
4D–H; Supplemental Fig. S4D,E). In support of these find-
ings, histological staining (proximal tibia) and μCT analy-
sis (distal femur) revealed increases in trabecular bone
volume and trabecular numbers in OSX-Cre; Hif2dPA
when compared with sex- and age-matched littermate
controls (Fig. 4I). Quantification of μCT images confirmed
a 2.5-fold increase in trabecular bone volume in the meta-
physeal region associated with a significant increase in
trabecular numbers in OSX-Cre; Hif2dPA (Fig. 4J). Impor-
tantly, while we did note induction of the HIF target gene
Vegf in whole-bone homogenates isolated from OSX-
Cre; Hif1dPAmice, demonstrating stabilization and tran-
scriptional activation of HIF-1α, consistent with data
reported by Kim et al. (2006), this induction was lower
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than transcriptional activation by HIF-2α (Supplemental
Fig. S4C). As such, we could not dismiss the possibility
that HIF-1α also has the potential to induce expression
of OPG andmodulate osteoclastogenesis. Taken together,
our data indicate that augmented HIF signaling in osteo-
progenitor cells is sufficient to alter bone homeostasis
through the up-regulation of OPG and subsequent inhibi-
tion of osteoclastogenesis.
Figure 4. HIF regulates osteoblastic OPG to modulate osteoclastogenesis. (A) Real-time PCR analysis of OPG and VEGF expression in
MC3T3 E1 cells exposed to 21%oxygen (Nx) or 0.5%oxygen (Hx). (B) Real-time PCR analysis of OPG expression ofMC3T3 E1 cells trans-
fected with constitutively active variants of HIF-1α (HIF-1dPA) or HIF-2α (HIF-2dPA). (C, top) Schematic representation of the mouse
Tnfrsf11b (OPG) promoter upstream of the transcriptional start site (TSS). Four potential HIF-binding sites (hypoxia-responsive element
[HREs]) are indicated withwhite boxes. (Bottom) Chromatin immunoprecipitation (ChIP) assay analysis of HIF-2 binding to HREs located
within the OPG promoter in MC3T3 E1 cells transfected with a nondegradable HA-tagged variant of HIF-2α. HIF-2α occupancy on the
VEGF promoter HRE was used as the positive control. (D) Real-time PCR analysis of OPG mRNA from whole-bone homogenates of
12-wk-oldmice. For each group analyzed,n = 3. (E) Analysis of OPGprotein levels in the serumof 12-wk-oldmice as determined by ELISA.
For each group analyzed, n = 4. (F ) Representative images of TRAP-stained proximal tibias isolated from 12-wk-old mice. (G,H) Quanti-
fication of TRAP-positivemultinucleated trabecular (G; n = 5) and endosteal (H; n = 3) osteoclasts in proximal tibias by analyzing the num-
ber of osteoclasts per bone surface (N.Oc./BS). (I, top) Representative μCT images of distal femurs (axial view of metaphyseal region)
isolated from 12-wk-old mice. (Bottom) Representative images from H&E staining of proximal tibias isolated from 12-wk-old mice. (J)
μCT analysis of distal femurs of trabecular bone volume (BV/TV) and trabecular number (Tb.N) from 12-wk-old mice. (CNTRL) Control;
(HIF1dPA) OSX-Cre; Hif1dPA; (HIF2dPA) OSX-Cre; HIf2dPA. (K, top) Representative μCT images of distal femurs (axial view of metaphy-
seal region) isolated from 12-wk-old mice. (Bottom) Representative H&E images of proximal tibias isolated from control (CNTRL) and
OSX-Cre; Phd2fl/fl; Phd3fl/fl; HIF2αfl/fl (PHD2/3/H2) mice. (L) μCT analysis of trabecular bone volume (BV/TV) and trabecular number
(Tb.N) from 12-wk-old mice isolated from control (C) and OSX-Cre; Phd2fl/fl; Phd3fl/fl; HIF2αfl/fl (PHD2/3/H2) mice. For each group ana-
lyzed, n = 5. All data are represented as mean ± standard error of the mean (SEM). (∗) P < 0.05; (∗∗) P < 0.01; (∗∗∗) P < 0.001, determined by
Student’s t-test. Note: Data shown from CNTRL and PHD2/3 mice are taken from Figure 2.
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Next, to determine whether HIF-2α was necessary for
PHD2- and PHD3-mediated changes in bone homeostasis,
we conditionally inactivatedHIF-2α in OSX-Cre; Phd2fl/fl;
Phd3fl/fl mice. μCT and histological analysis of OSX-
Cre; Phd2fl/fl; Phd3fl/fl; Hif2αfl/flmice revealed that condi-
tional deletion ofHIF-2α resulted in a complete abrogation
of the observed bone phenotype in OSX-Cre; Phd2fl/fl;
Phd3fl/fl (Fig. 4K). Quantification of μCT analysis con-
firmed these observations, demonstrating the normaliza-
tion of bone volume and trabecular numbers (Fig. 4L).
Examination andquantificationof the osteoclast compart-
ment revealed no significant differences in either TRAP-
stained osteoclasts or OPG and RANKL mRNA in OSX-
Cre; Phd2fl/fl; Phd3fl/fl; HIF2αfl/fl mice when compared
with age- and sex-matched littermate controls (Supple-
mental Fig. S4G,H). Collectively, these data demonstrate
that HIF-2α is necessary within the context of combined
PHD2 and PHD3 inactivation to inhibit bone resorption
through osteoblastic modulation of OPG.
Repression of endogenous HIF signaling enhances
osteoclastogenesis
To test the requirement for PHD/HIF signaling in modu-
lating the physiologic expression of OPG, we used mice
inwhich conditional alleles for HIF-1α andHIF-2α contain
Lox-P sites flanking exon 2 (which encodes theDNA-bind-
ingdomain), resulting in anout-of-framedeletionof exon2
and the loss of HIF-1α or HIF-2α expression following Cre
recombination (Ryan et al. 1998; Gruber et al. 2007). In vi-
tro, inactivation of HIF-1α and HIF-2αwas achieved by in-
fecting primary osteoblasts isolated from these mice with
adenovirus driving the expression of Cre-recombinase. In
response to hypoxia, loss of either HIF-1α or HIF-2α result-
ed in diminishedmRNA expression of the HIF target gene
Pgk (Fig. 5A,B). Interestingly, inactivation ofHIF-2α result-
ed in diminishedOPGmRNAexpression (Fig. 5B), indicat-
ing a requirement of HIF signaling for the regulation of
osteoblastic OPG expression in response to hypoxia.
Figure 5. Loss of both HIF-1α and HIF-2α is necessary to alter osteoclastogenesis. (A,B) Real-time PCR analysis of PGK (left) and OPG
(right) mRNA expression in primary osteoblast cultures isolated fromHif-1αfl/fl (HIF-1fl/fl) orHIF-2αfl/fl (HIF-2fl/fl) mice exposed to hyp-
oxia (0.5% oxygen) and infected with adenovirus to drive expression of Cre-recombinase. (C,D) Real-time PCR analysis of OPG mRNA
fromwhole-bone homogenates (C ) and quantification of TRAP-positive multinucleated trabecular and endosteal osteoclasts (D) in prox-
imal tibias of 12-wk-old OSX-Cre; Hif-1αfl/fl (n = 3). mice (E,F ) Real-time PCR analysis of OPGmRNA from whole-bone homogenates (E)
and quantification of TRAP-positivemultinucleated trabecular and endosteal osteoclasts (F ) in proximal tibias of 12-wk-oldOSX-Cre; Hif-
2αfl/fl mice (n = 3). (G) Representative images of TRAP-stained proximal tibias. TRAP-positive cells are stained in purple. (H) Real-time
PCR analysis of OPGmRNA in bone tissues isolated from 12-wk-oldmice (n = 3). (I ) Quantification of TRAP-positive trabecular and end-
osteal multinucleated osteoclasts in proximal tibias of 12-wk-old mice (n = 3). All data are represented as mean ± standard error of the
mean (SEM). (∗∗) P < 0.01; (∗) P < 0.05, determined by Student’s t-test.
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Next, to determine whether HIF-mediated modulation
of osteoblastic OPG functionally contributes to osteoclas-
togenesis, HIF-1αfl/fl and HIF-2αfl/fl mice were crossed to
mice expressing the Cre-recombinase under the control
of the osterix promoter. Consistent with previously pub-
lished results, we noted diminished trabecular bone vol-
ume in our OSX-Cre; Hif-1αfl/fl and OSX-Cre; Hif-1/Hif-
2αfl/fl mutant mice when compared with littermate
controls (Supplemental Fig. S5A–C;Wang et al. 2007; Sho-
mento et al. 2010; Rankin et al. 2012). Analysis of femurs
isolated from 12-wk-oldOSX-Cre; Hif-1αfl/flmice revealed
no differences in OPG mRNA expression, trabecular or
endosteal osteoclast numbers, or trabecular osteoblast
numbers (Fig. 5C,D; Supplemental Fig. S5D). Intriguingly,
analysis of bones isolated from 12-wk-old OSX-Cre; Hif-
2αfl/fl mice showed that despite lowered levels of OPG
mRNA, only a modest increase in trabecular and endoste-
al osteoclast numberswas observed; however, these differ-
ences did not reach statistical significance (Fig. 5E,F). This
suggests that HIF-2α is able to regulate OPG expression in
vivo but that loss of HIF-2α alone does not significantly
impact osteoclastogenesis.
Combined loss of osteoblastic HIF-1α and HIF-2α re-
sults in diminished trabecular bone volume; however,
the angiogenesis-independent rolesmediating this pheno-
type remain unclear (Shomento et al. 2010; Rankin et al.
2012). While we did not detect differences in osteoclast
numbers in either OSX-Cre; Hif-1αfl/fl or OSX-Cre; Hif-
2αfl/flmice, we did observe an increased trend in osteoclast
numbers. As such, we sought to determine whether oste-
oblastic inactivation of both HIF-1α and HIF-2α could
enhance osteoclastogenesis. Examination and quantifica-
tion of TRAP-stained femurs isolated from OSX-Cre;
Hif-1αfl/fl; Hif-2αfl/fl mice revealed a significant increase
in trabecular osteoclast numbers and an increased trend
in endosteal osteoclast numbers when compared with
age- and sex-matched littermate controls (Fig. 5G,I).
Real-time PCR analysis of whole-bone homogenates re-
vealed significant differences in OPG mRNA expression
between control and mutant mice (Fig. 5H). Thus, com-
bined loss of HIF-1α and HIF-2α is required to enhance
osteoclastogenesis, which may be mediated in part
through an OPG-dependent pathway.
Osteoblastic inactivation of PHD2 and PHD3modulates
OPG to prevent bone loss
Weidentified osteoblastic PHDs as regulators of both bone
and blood homeostasis. Importantly, we also showed that
selective inactivation of specific PHD isoforms could in-
crease trabecular bone while avoiding the aberrant angio-
genic and hematopoietic effects associated with loss of
pVHLor all three PHD isoforms. Taken together, these ob-
servations raised the intriguing possibility that precise
modulation of the HIF signaling pathway through the
selective inhibition of osteoblastic PHDshad the potential
to protect against chronic bone disorders such as osteopo-
rosis. This could be achieved by regulating the communi-
cation between osteoblasts and osteoclasts without the
detrimental effects to bone and blood tissues associated
with uncontrolled HIF activation. To evaluate the poten-
tial therapeutic application of PHD2 and PHD3 inactiva-
tion for protection against pathological bone loss, we
sham-operated or ovariectomized 3-mo-old control and
OSX-Cre; Phd2fl/fl; Phd3fl/fl mice to determine whether
PHD2 and PHD3 modulation of OPG could protect mice
against bone loss. Upon ovariectomy, uterine weight was
significantly diminished in both sets of ovariectomized
mice when compared with sham-operated controls (Sup-
plemental Fig. S6). Six weeks after surgery, histological
and quantitative µCT analysis of control mice revealed a
50% decrease in trabecular bone volume in ovariecto-
mized mice when compared with sham-operated controls
(Fig. 6A–C). In contrast, ovariectomized OSX-Cre; Phd2fl/
fl; Phd3fl/fl mutant mice were protected against this bone
loss (Fig. 6A–C). Consistent with our previous findings,
loss of PHD2 and PHD3 led to the normalization of the
OPGserum levels and a re-establishment of physiological-
ly normal numbers of osteoclasts in ovariectomized mice
(Fig. 6D–F). These results demonstrate that osteoblastic
inactivation of PHD2 and PHD3 has the potential to pro-
tectmice against post-ovariectomybone loss by inhibiting
the excessive and unbalanced rate of bone turnover and in-
dicate the potential of selective PHD inhibitors as a new
therapeutic modality in the treatment of osteoporosis.
Discussion
The osteoblastic niche houses cells of the osteoblastic
and hematopoietic lineages residing in areas of variable ox-
ygen tension. In this dynamic microenvironment, HIF-
mediated signaling is active and functionally important;
however, the mechanisms by which the oxygen-sensing
PHD isoenzymes regulate osteoblast function and bone
homeostasis remain largely unknown. Through the use
of conditional inactivating mutations, our study system-
atically elucidated the role of the cellular oxygen sensors
in the bone, providing deep mechanistic insights into
how PHD/HIF signaling regulates bone homeostasis and
howthispathwaycanbepotentiallyexploited for the treat-
ment of chronicmetabolic bonedisorders.Here,weshowa
previously unreportedmechanismbywhich PHDoxygen-
sensing enzymes modulate trabecular bone homeostasis
by controlling the dosage of HIF signaling by directing tar-
get gene expression to coordinate two important aspects
of bone physiology: cross-talk between osteoblasts and os-
teoclasts and angiogenic/osteogenic coupling.
A recent study by Kusumbe et al. (2014) identified re-
gionally defined areas of hypoxia within the bone marrow
microenvironment and revealed that a specific subtype of
endothelial cells is associated with functionally active
HIF signaling to regulate the coupling of angiogenesis to
osteogenesis. However, within a reduced oxygen environ-
ment, the cell-autonomous mechanism by which HIF
signaling regulates osteoblast function and bone homeo-
stasis remains poorly understood. In support of previous
findings, our study shows that extreme HIF activation
through genetic inactivation of all three PHDs enhances
bone formation through VEGF-mediated angiogenesis.
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Here, we present evidence indicating that PHD/HIF sig-
naling has additional functions in skeletalgenesis. Unex-
pectedly, the combined genetic inactivation of Phd2 and
Phd3 led to modest HIF target gene activation and a mod-
erate increase in trabecular bone volume. Importantly,
this phenotype was not associated with increased angio-
genesis but rather the suppression of osteoblast-mediated
osteoclastogenesis through themodulation of OPG.Nota-
bly, previous studies augmenting HIF signaling in bone
have used genetic inactivation of pVHL or constitutive
activation of HIF-1α, which leads to severe HIF activation
(Wang et al. 2007; Regan et al. 2014). In contrast, as PHD
enzymatic activity is regulated by oxygen availability,
these enzymes provide the link between oxygen availabil-
ity and HIF activation, and, as such, our study provides a
complete and nuanced understanding of howhypoxia con-
tributes to bone homeostasis.
Our study identified OPG as a new osteoblastic HIF
target gene. We discovered functional HIF-binding sites
within the Tnfrsf11b (OPG) promoter and report that con-
stitutive activation of PHD/HIF signaling resulted in di-
rect binding of HIF-2α to these regions. We report that
HIF-mediated signaling is both sufficient and necessary,
in the context of PHD2 and PHD3 inactivation, to modu-
late OPG expression to direct osteoblast-mediated osteo-
clastogenesis. We show that a twofold induction in OPG
mRNAmay have the potential to alter bone homeostasis.
In support of our work, Movérare-Skrtic et al. (2014) also
demonstrated that a twofold reduction in OPG was asso-
ciated with diminished bone strength. In vivo, we found
that enhanced trabecular bone volume was associated
with a threefold increase in OPG mRNA expression.
These changes are in accordance with other mouse mod-
els in which stabilization of β-catenin increased bone
formation through the up-regulation of OPG (Glass et
al. 2005). Importantly, we cannot dismiss the possibility
that augmented PHD/HIF signaling may mediate other
signaling events that contribute to the modulation of
bone homeostasis seen in vivo. For example, the Wnt/ca-
nonical β-catenin signaling pathway has been shown to
directly bind to and up-regulate OPG expression to impair
bone resorption (Glass et al. 2005). While our data demon-
strate a direct regulation of OPG by PHD/HIF signaling,
we cannot rule out the possibility that hypoxia and HIF
may also indirectly regulate OPG, osteoclastogenesis,
and bone homeostasis through indirect effects on other
pathways such as the WNT/β-catenin pathway.
While previous reports show that osteoblastic loss of
HIF-1α and HIF-2α results in diminished trabecular bone
volume, the angiogenesis-independent roles mediating
Figure 6. Osteoblastic inactivation of PHD2 and PHD3modulatesOPG to protectmice against bone loss. (A) Representative μCT images
of distal femurs (axial view of metaphyseal region) isolated from sham-operated (SHAM) and ovariectomized (OVX) control (CNTRL) and
OSX-Cre; Phd2fl/fl; Phd3fl/fl (PH2/3)mice. (B) Representative images of H&E-stained proximal tibias isolated from sham-operated (SHAM)
and ovariectomized (OVX) control (CNTRL) and OSX-Cre; Phd2fl/fl; Phd3fl/fl (PH2/3) mice. (C ) μCT analysis of trabecular bone volume
(BV/TV) and trabecular number (Tb.N) for sham-operated (SHAM) and ovariectomized (OVX) control (CNTRL) and OSX-Cre; Phd2fl/fl;
Phd3fl/fl (PH2/3) mice. For each group analyzed, n = 9. (D) Representative images of TRAP-stained proximal tibias. The arrowheads point
to TRAP-positive osteoclasts. (E) Quantification of TRAP-positive multinucleated osteoclasts in proximal tibias of sham-operated
(SHAM) and ovariectomized (OVX) control (CNTRL) and OSX-Cre; Phd2fl/fl; Phd3fl/fl (PHD2/3) mice. (N.Oc./BS) Number of osteoclasts
per bone surface. (F ) Analysis of OPGprotein levels in the serumof sham-operated (SHAM) or ovariectomized (OVX) control (CNTRL) and
mutant mice as determined by ELISA (n = 6). For all experiments, operations were performed at 12 wk of age, and 6 wk post-surgery bone
parameterswere assessed.Data are represented asmean ± standard error of themean (SEM). (∗∗) P < 0.01; (∗∗∗∗) P < 0.0001, as determined by
Student’s t-test.
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this phenotype remain unclear (Shomento et al. 2010).We
did not detect differences in osteoclast numbers in either
OSX-Cre; Hif-1αfl/fl or OSX-Cre; Hif-2αfl/fl mice despite a
reduction in OPG mRNA in OSX-Cre; Hif-2αfl/fl mice.
However, combined loss of osteoblastic HIF-1α and HIF-
2α resulted in diminished osteoclast numbers accompa-
nied by a reduction of trabecular bone exceeding that of
loss of HIF-1α alone. Importantly, Shomento et al. (2010)
reported that loss of HIF-2α in osteoblasts was not associ-
ated with a significant loss in trabecular bone despite a
significant decrease in bone vasculature. Given these find-
ings, we hypothesize that HIF-1α under normal physiolog-
ical settings may play a predominant role in regulating
osteogenesis coupled to angiogenesis, and this may im-
pact the subsequent recruitment of osteoclast precursors
to areas of bone remodeling. In contrast, HIF-2α may
also contribute to bone remodeling in part by regulating
the interactions between osteoblasts and osteoclasts
through the modulation of OPG.
Importantly, we show that PHDs in osteoblasts can
modulate the cross-talk between osteoblasts and osteo-
clasts. This previously unreported relationship between
HIF transcription factors and the RANK/RANKL/OPG
signaling axis also has important clinical implications,
as deregulation of the OPG/RANK/RANKL pathway is a
critical molecular driver in the development of post-men-
opausal osteoporosis. Moreover, we demonstrated that ge-
netic inactivation of all three PHD isoforms resulted in
excessively ossified bone associated with enhanced mi-
crovascular density, reduction in bonemarrow cellularity,
and the development of polycythemia. Thus, for clinical
purposes, long-term activation of PHD/HIF signaling
within the bone marrowmicroenvironment has potential
detrimental effects for both bone and hematopoietic tis-
sue and should therefore be approached with caution, as
unmitigatedHIF activation can lead to extremeVEGF pro-
duction, which has been shown to result in excessively os-
sified bone (Maes et al. 2010b).
However, it should be noted that transient activation of
the HIF signaling pathway through pharmacologic pan-in-
hibition of PHDs through the use of either iron cheaters
(such as desferrioxamine [DFO]) or 2-oxyglutarate analogs
(such as dimethyloxalyglycine [DMOG]) increases VEGF-
mediated vascularization at the fracture site and promotes
callus formation and efficient healing during fracture
repair (Wan et al. 2008; Shen et al. 2009). Hence, for acute
bone injuries, limited and transient activation of PHD/
HIF signaling may prove to be beneficial by enhancing
blood vessel invasion and the recruitment of new osteo-
progenitors, both of which are critical mediators for
efficient and proper bone healing after fractures. Given
these observations, it has been postulated that pan-PHD
inhibitors could also be used for the treatment of chronic
metabolic bone disorders such as osteoporosis (Zhao et
al. 2012). In support of this hypothesis, DMOG has been
shown to increase trabecular bone and bone strength
mediated by VEGF-induced angiogenesis; however, it
should be noted that these experiments were performed
on rats over a relatively short period of time (Liu et al.
2013). Furthermore, in these studies, examination of the
hematopoietic compartment was not performed to de-
termine whether hematopoietic hemostasis was main-
tained during the course of treatment. Taken together,
the efficacy of using pan-PHD inhibitors for the treatment
of osteoporosis when long-term, excessive chronic expo-
sure would be required has yet to be proven. Our findings
suggest that selective rather than collective inhibition
of PHD isoenzymes should be explored as protection
against metabolic bone disorders to avoid the potential
tissue-damaging effects of prolonged, chronic, and ex-
cessive HIF activation. In addition, selective inactivation
of PHD2 and PHD3 enhances trabecular bone volume
through modulation of the OPG, thereby specifically tar-
geting themolecularmechanism driving the pathogenesis
of this disease.
We show that “fine-tuning” of osteoblastic HIF sig-
naling in bone tissue through specific PHD isoform in-
activation can control the dosage of HIF signaling to
differentially activate HIF target genes (Fig. 7). Important-
ly, precise modulation of HIF activation is associated
with functional bone accumulation and hematopoietic
Figure 7. Selective inactivation of PHDs regulates HIF signaling
dosage to differentially modulate bone homeostasis. Selective in-
activation of PHDs modulates the dosage of HIF signaling with
functional consequences for bone and hematopoietic homeosta-
sis. We show that, by acting as amolecular rheostat of HIF activa-
tion, genetic inhibition of specific PHD isoform combinations
differentially regulates two important aspects of bone physiology:
cross-talk between osteoblasts and osteoclasts and angiogenic/os-
teogenic coupling. In conditions where genetic inactivation of
three PHD isoforms occurs, robust HIF activation ensues, leading
to enhanced angiogenesis that results in extreme ossification of
trabecular bones and aberrant hematopoiesis. In contrast, the
loss of specific dual combinations of PHD isoforms does not alter
microvascular density or hematopoietic homeostasis but does en-
hance trabecular bone volume. This enhancement is due to HIF-
mediated suppression of osteoblast-mediated osteoclastogenesis
through the modulation of OPG.
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homeostasis rather than the accumulation of trabecular
bone that obliterates the bone marrow cavity. Further-
more, wewere able to delineate between PHD/HIF regula-
tion of bone and hematopoietic homeostasis. Importantly,
PHDs are current therapeutic targets for the regulation
of HIF in the treatment of anemia and wound healing
(Myllyharju 2008; Minamishima and Kaelin 2010). How-
ever, currently available HIF hydroxylase inhibitors lack
specificity for individual PHD isoenzymes, highlighting
the importance of developing isoform-specific inhibitors
as a possible treatment modality to protect against osteo-
porosis that is not associated with the potential develop-
ment of tissue toxicity (Fraisl et al. 2009). We did not
detect changes in cortical bone, a large determinant of
bone strength and nonvertebral fracture risk. However,
trabecular bone is important for the prevention of osteo-
porosis, particularly for the impediment of vertebral frac-
tures, which result in pain, functional disability, and
decreased quality of life (Gerdhem 2013; Iki et al. 2014).
Therefore, the resulting increases in trabecular bone vol-
ume afforded by PHD2 and PHD3 inactivation may have
important clinical implications. In summary, we have
begun to unravel the means by which oxygen availability
and PHD oxygen sensors act as the molecular rheostat of
HIF activation to differentially activate HIF target genes
and functionally contribute to several physiological pro-
cesses that control trabecular bone homeostasis.
Materials and methods
Generation of mice
Generation and genotyping analysis of the Phd1fl/fl; Phd2fl/fl;
Phd3fl/fl, Hif-1dPA, Hif-2dPA, Hif-lfl/fl, Hif-2fl/fl, and OSX-Cre
transgenic mice have previously been described (Ryan et al.
1998; Kim et al. 2006; Rodda and McMahon 2006; Takeda et al.
2006, 2008; Gruber et al. 2007). OSX-Cre; Phdfl/fl mice were gen-
erated in mixed C57/B6 and FVB/N genetic backgrounds. There-
fore, for all studies with these mice, littermate Cre-recombinase-
positive heterozygous floxedmice and Cre-negative homozygous
floxed mice were used as controls. OSX-Cre; Hif-1dPA and OSX-
Cre; Hif-2dPA mice were bred on a C57/B6 genetic background.
For all studies, age- and sex-matched littermates were used as
controls. All procedures involving mice were performed in accor-
dance with the National Institutes of Health (NIH) guidelines for
the use and care of live animals andwere approved by the Stanford
University Institutional Animal Care and Use Committee.
Cell culture
MC3T3 E1 cells (American Type Culture Collection) were main-
tained in αMEM (Life Technologies) with 10% FBS (HyClone) (v/
v) at 37°C in a humidified incubator supplied with 5% CO2.
Transfections were carried out using polyethylenimine (Sigma).
Briefly, MC3T3 E1 cells were incubated with a ratio of 50 μg of
DNA:2 μg of polyethylenimine for 6 h, after which cells were
rinsed with αMEMand incubated for 24 h prior for endpoint anal-
ysis (see below). For hypoxia treatments, cells were plated 12 h
prior to placement into a hypoxia chamber (Invivo2-400, Ruskin
Technologies) and maintained at 0.5% oxygen for 24 h. All
endpoints measured for cells under hypoxic conditions were
compared with cells cultured under normoxic conditions (21%
oxygen). Cocultures were prepared as previously described (Mov-
érare-Skrtic et al. 2014). Briefly, mouse calvarias osteoblast cells
from PHD2fl/fl; PHD3fl/fl mice were treated with adeno-CRE or
control virus for 24 h as previously described (Wang et al. 2007;
see below). Next, cells were treated with complete osteogenic
αMEM. After 6 d, bone marrow stromal cells from wild-type
mice were added, and osteoclastogenesis was induced by cultur-
ing cells in complete osteogenic αMEM medium with 10 nM
1,25-dihydroxy-vitamin-D3 and 1 μM PGE2.
Osteoblast isolation
Bonemarrow stromal cells from postnatal day 1 pups were isolat-
ed by serial collagenase digestion as previously described (Wu
et al. 2008). Fractions 3–6 were plated in αMEM supplemented
with 10% FBS and incubated under 5% oxygen for 4 d to reach
confluence.
cDNA constructs
pCDNA3.1 HA-Hif2 proline mutants were purchased from
Addgene.
Viral infections
Primary osteoblasts frommutantmicewere isolated frompostna-
tal day 1 pups. Cells were grown to confluence and infected with
control (Ad-GFP) or Cre-recombinase virus (Ad-Cre) (Vector Lab-
oratories) at amultiplicity of infection (MOI) of 200. TotalmRNA
was extracted from infected osteoblasts for endpoint analysis.
Protein isolation and Western blot analysis
Protein lysates were isolated in RIPA buffer, and quantification
was assessed using a Bradford assay (Bio-Rad). Fifty micrograms
of protein was subjected to reducing SDS-PAGE using standard
methods.Western blots were probedwith antibodies against β-ac-
tin (Sigma), anti-HIF-2 (Novus), anti-HA (Sigma), anti-PHD1
(Abcam), anti-PHD2 (Novus), and anti-PHD3 (Novus). Antibod-
ies were diluted in Superblock TBS solution (Pierce) and main-
tained at 4°C.
Promoter analysis and ChIP assay
The Tnfrsf11B (OPG) promoter was searched for consensus HREs
containing a conserved RCGTG sequence. Potential HREs lo-
cated within the Tnfrsf11b gene and promoter regions were pre-
dicted using the JASPAR CORE database with a relative score
threshold of 0.85. ChIP assay was performed as described pre-
viously with the following modifications (Krieg et al. 2010).
MC3T3-E1 cells were fixed 24 h after transfection with control
or pcDNA 3.1 HIF-2-HA constructs (Addgene). Lysed cells were
sonicated using a Bioruptor plus sonication system (Diagenode,
Inc.) set at high power, 30 sec on, 90 sec off, and 60 cycles. Approx-
imately 150 μg of sonicated chromatin was incubated overnight
with rabbit anti-HA antibody (Abcam) followed by precipitation
with protein A/G Dynabeads (Invitrogen). Normal rabbit IgG
(SantaCruz Biotechnology) was used as a nonspecific IgG control.
Five percent of the sample from each immunoprecipitation was
reserved for input control. Relative enrichment was measured
by qRT–PCR using a titration of pooled input samples as a
standard curve and normalized to input after subtraction of IgG
signal. Enrichments are presented as fold change relative to
mock control.
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Quantitative μCT analysis
Femurs and tibias from12-wk-oldmicewere dissected, soft tissue
was removed, and boneswere fixed in 10%buffered formalin for 5
d and then stored in 70% ethanol. Ex vivo specimens were
scanned at a voxel size of 10.5 μm (μCT40, Scanco Medical). Tra-
becular bone analysis of distal femurs was performed using ac-
quired images beginning 0.5 mm below the distal growth plate
and extending proximally for 2.0 mm. For trabecular bone analy-
sis of tibias, analysis was performed over a 1.3-mm region begin-
ning 0.4 mm below the proximal growth plate. Cortical bone
analysis was performed using 1.0-mm transverse cross-sectional
sections in themid-diaphyseal region of the femur. For trabecular
bones, each μCT image shown represents a 10-μmtransverse slice
0.8 mm below the femoral distal growth plate. We applied a
threshold of 170 to all scans at high resolution (E = 55 kVp, I =
72 μA, integration time = 200 msec), and standard algorithms
were used to calculate the following parameters: bone volume/to-
tal volume (BV/TV), trabecular number (Tb.N.), trabecular thick-
ness (Tb.Th.), trabecular separation (Tb.Sp.), cortical thickness
(Ct.Th.), total cross-sectional area (Tt.Ar), cortical bone area
(Ct.Ar), medullary area, and cortical area fraction (Ct.Ar/Tt.Ar).
Histomorphometry and immunohistochemistry
For dynamic histomorphometry, calcein green was injected on
day 1 followed by a second injection on day 7. Mice were eutha-
nized 2 d after the second injection. Undecalcifed femurs were
embedded in methymethacrylate. In vivo osteoclast and osteo-
blast parameters were generated from paraffin sections of decalci-
fied tibias stained with TRAP or H&E, and images were analyzed
using Bioquant software (Bioquant Image Analysis). Osteoclast
number normalized to the bone surface (N.Oc/Bs) was quantified
on TRAP-stained sections according to the manufacturer’s in-
structions (Sigma) at 200× magnification. All measurements
were taken in an area located 0.5 mm below the growth plates.
HIF-1α and HIF-2α were detected with rabbit anti-human/mouse
HIF-2α polyclonal antibody (Novus) and rabbit anti-human/
mouse HIF-1α (Bethyl Laboratories) at a dilution of 1:100. CD31
was detected with rat anti-mouse CD31 antibody (BD 550274)
at a dilution of 1:200. Endomucin was detected with rat anti-
mouse endomucin antibody (Abcam) at a dilution of 1:50. All an-
tibodies were incubated overnight at 4°C and developed with the
TSA biotin system (Perkin-Elmer) according to the manufactur-
er’s protocol.
Ovariectomy-induced bone loss
Twelve-week-old female mice were ovariectomized or sham-op-
erated. Six weeks after surgery, mice were euthanized and sub-
jected to bone analysis as described above.
DNA and RNA isolation
DNA was isolated according to Laird et al. (1991) and used for
genomic PCR. RNA was isolated using Trizol reagent according
to the manufacturer’s instructions (Invitrogen).
Real-time PCR
Real-time PCR was performed as previously described (Rankin
et al. 2012). For 18S amplification, cDNA was diluted 1:50. The
following primers were used to amplify specific target genes:
Epo (FWD, 5′-CATCTGCGACAGTCGAGTTCTG-3′ and REV,
5′-CACAACCCATCGTGACATTTT C-3′ ), 18S (FWD, 5-GCCC
GAAGCGTTTACTTTGA-3′ and REV, 5-TCCATTATTCCTA
GCTGCGGTATC-3′), Pgk (FWD, 5′-GGAAGCGGGTCGTGA
TGA-3′ and REV, 5′-GCCTTGATCCTTTGGTTGTTTG-3′),
Vegf (FWD, 5′-CCACGTCAGAGAGCAACATCA-3′ and REV,
5′-TCATTCTCTCTATGTGCTGGCTTT-3′), Opg (FWD, 5′-A
GCTGCTGAAGCTGTGGAA-3′ and REV, 5′-GGTTCGAGT
GGCCGAGAT-3′), and Rankl (FWD, 5′-ATGAACAAGTGGCT
GTGCTG-3′ and REV, 5′-TGTCACACAGGAGCTGATGA-3′).
ELISA
OPG and RANKL ELISA was performed according to the manu-
facturer’s instructions with the exception that the serum was in-
cubated in the ELISA plate overnight at 4°C (R&D Systems).
Statistical analysis
Statistical analysis was performed using Prism software (Graph-
Pad). In all cases, a two-tailed, unpaired Student’s t-test was per-
formed to analyze the statistical differences between groups.
P-values of <0.05 were considered statistically significant.
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